| Synonyms: | |
| Status: | Approved (2019) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC37 |
| UNII: | KG6VO684Z6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-cell antigen receptor complex-associated protein beta chain binding agent |
| Primary Target | |
|---|---|
| CD79B |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, B-Cell | 4 | D016393 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Lymphoma, B-Cell, Marginal Zone | 2 | D018442 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Lymphoma, B-Cell, Marginal Zone | 2 | D018442 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1313206-42-6 |
| ChEMBL | CHEMBL3301582 |
| FDA SRS | KG6VO684Z6 |
| Guide to Pharmacology | 8404 |
CONTENTS